Ammonium dihydrogen phosphate
Common Name: |
Ammonium dihydrogen phosphate |
IUPAC Name: |
azanium;dihydrogen phosphate |
Molecular Formula: |
NH4H2PO4 |
SMILES: |
[NH4+].OP(=O)(O)[O-] |
Inchi: |
1S/H3N.H3O4P/c;1-5(2,3)4/h1H3;(H3,1,2,3,4) |
Inchi Key: |
LFVGISIMTYGQHF-UHFFFAOYSA-N |
Cas No: |
7722-76-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
115.03 |
Mass (g/mol) |
115.003 |
Molar Refractivity |
18.72 |
Net Charge |
|
HBD |
5 |
HBA |
6 |
Rt Bonds |
0 |
Rings |
|
TPSA |
90.40 |
Hetero Atoms |
|
Heavy Atoms |
6 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
190 |
Boiling Point (°C@760.00mm Hg) |
158 |
Vapor Pressure (mmHg@25.00 °C) |
1.41 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
|
iLOGP |
0.52 |
XLOGP3 |
-2.84 |
WLOGP |
-3.22 |
MLOGP |
-2.75 |
ESOL Log S |
0.90 |
ESOL Solubility (mg/ml) |
1430 |
ESOL Solubility (mol/l) |
7.91 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
1.08 |
Ali Solubility (mg/ml) |
2160 |
Ali Solubility (mol/l) |
12 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
2.17 |
Silicos-IT Solubility (mg/ml) |
26300 |
Silicos-IT Solubility (mol/l) |
146 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
Low |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-9.42 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
0 |
Plasm Protein Binding |
1.039 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.449 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |